[October 30, 2014]

Research and Markets: European Clinical Trial Benchmarking Investigator Payments

Research and Markets (http://www.researchandmarkets.com/research/9lkp7h/benchmarking) has announced the addition of the "Benchmarking European Investigator Payments" report to their offering.

This report provides an analysis of Europe's clinical trial compensation for investigator payments across 18 therapeutic areas, 5 compound types, and the 4 phases of development. It provides pharmaceutical, biotech, and service providers an opportunity to gain a better understanding of what drives investigator payments so they can benchmark their payment levels and better pan for study costs.

WHAT YOU WILL LEARN IN THIS REPORT

- Average compensation investigators receive per subject for each therapy area by phase and compound orientation/ type

- How study characteristics (length and complexity) change fee levels

- What motivates investigators to participate in a trial

- Therapeutic area profiles

HOW YOU CAN USE THIS REPORT

- Optimize your investigator payments across therapeutic areas, phases of development, compound type under investigation, and geography

- Establish and better negotiate investigator payments

- Use 'trial complexity' and 'length of study' as variables to create more accurate budget projections and lower costs

Key Topics Covered:

1. Copyright and Usage Guidelines

2. Introduction

3. Methodology

4. Respondent Demographics and Qualifications

5. Major Sections

6. Executive Summary

7. Benchmarking Investigator Fees

8. Investigator Payment Dynamics

9. Drivers of Investigator Fees

10. Profiled Specialty/ Therapeutic Analysis

11. Site and Respondent Demographics

For more information visit http://www.researchandmarkets.com/research/9lkp7h/benchmarking

[ Back To TMCnet.com's Homepage ]